Skip to main content

Table 4 Receiver operator characteristic curve analysis of all biomarkers for predicting events (death/LVAD implantation/transplant).

From: Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy

Biomarker

AUC

95% CI

P

sST2

0.76

(0.59 - 0.93)

0.001

NT-proBNP

0.53

(0.32 - 0.74)

0.38

hsTnI

0.61

(0.40 - 0.81)

0.15

eTnI

0.64

(0.44 - 0.84)

0.08

cys-C

0.63

(0.42 - 0.83)

0.11

MPO

0.63

(0.43 - 0.83)

0.10

  1. AUC, area under the curve; CI, confidence intervals; cys-C, cystatin C; eTnI, experimental research prototype Troponin I; hsTnI, highly sensitive Troponin I; MPO, myeloperoxidase; NT-proBNP, amino terminal cleavage fragment of B-type natriuretic peptide; sST2, soluble ST2.